Developer of proprietary small molecule therapeutics designed for the treatment of auto-immune diseases. The company's therapeutics use a novel class of oral nucleotide synthesis inhibitors that can t...

Healthcare
Saint-Genis-Pouilly, France
Founded 2014
12 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$112M
Last Round
N/A